Q1 FY27 Quarterly Activities Report & Appendix 4C
Filed with ASX ·
6ix is reading this filing.
Microba Life Sciences Limited on 6ix
Earlier from Microba Life Sciences
- Microba secures $2m placement and increases cost reductions
- Appointment of Interim Chief Executive Officer
- GSS and MAP agree to Commercial Terms for Merger
- 2026 Annual Report & Appendix 4E
- Genetic Signatures and Microba in Merger Discussions
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences